Exchange: NASDAQ·Updated 03:44 PM EDT
CARM logo

CARM Carisma Therapeutics Inc

$0.0007
$0.0003
(30.00%)
Today
Reported EarningsAug 7
Mkt Cap$41,845.00
Vol6,207.00

About CARM

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
43

Bearish Sentiment

How do you feel about CARM?

Advertisement|Remove ads.